Q&A: How to make your dry eye practice unique

Video

Maria Sampalis, OD, shares how her practices is able to set itself apart from others within the dry eye field.

Maria Sampalis, OD, of Sampalis Eye Care in Cranston/Providence, Rhode Island, continues her dry eye discussion with Optometry Times®' Kassi Jackson by diving into the business side.

She shares how her practice is able to set itself apart from others also treating dry eye—including tips for community outreach and digital expansion— and why she believes the medical model is the future of optometry.


Watch previous installments of this interview on dry eye treatments:

Q&A: What are common visual habits that lead to dry eye?
Q&A: How to start the dry eye conversation with patients
Q&A: Factors to consider when treating dry eye patients
Q&A: Pandemic's effect on dry eye patient numbers

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Selina McGee, OD, shares what she wants to see in future State of Dry Eye surveys and how this year's results will affect her patient care.
Selina McGee, OD, FAAO, Dipl ABO, shares key takeaways and a personal anecdote relating to the State of Dry Eye survey results.
Reviewing the State of Dry Eye Survey with Selina McGee, OD, FAAO, Dipl ABO.
Shelby Brogdon, OD, details opportunities for practices to answer the patient's concerns from the chair before they hit the internet for their contact lens needs.
Jacob Lang, OD, FAAO, details early symptom relief demonstrated in as early as day 1 during AOA's Optometry's Meeting 2025.
Mitch Ibach, OD, FAAO, details the importance to unveiling the underlying cause of dry eye in a CCS 2025 presentation.
Bridgitte Shen Lee, OD, FAAO, FBCLA, FEAOO, ponders what she would like to see develop as both a researcher and a clinician in the dry eye space.
Bridgitte Shen Lee, OD, FAAO, FBCLA, FEAOO, discussed research that utilized IQVIA longitudinal prescription claims data from September through November 2023, coinciding with Miebo's FDA approval in September.
Dr Julie Poteet reports on patient-reported outcomes using lipid-containing artificial tear
What to know about legislative moves that have been made through May this year.
© 2025 MJH Life Sciences

All rights reserved.